Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published online in The Lancet Infectious Diseases.
The results are significant as public health experts have long warned that the parasite responsible for most malaria cases, Plasmodium falciparum, is developing resistance to widely used treatments. New medications are needed to build up secondary defenses against drug-resistant strains of the parasite.
The drug, called AQ-13, was able to clear the parasite responsible for the disease within a week, matching the effectiveness of the most widely used treatment regimen.
“The potential long-term implications are bigger than one drug. The conceptual step here is that if you understand the resistance well enough, you may be actually be able to develop others as well.”
Dr. Donald Krogstad
“The clinical trial results are extraordinarily encouraging,” said Dr. Donald Krogstad, senior author and professor of tropical medicine at Tulane University School of Public Health and Tropical Medicine. “Compared to the current first-line recommendation for treatment of malaria, the new drug comes out very well.”
Mosquitoes infected by a parasite spread malaria, causing more than 200 million illnesses across the globe and more than 400,000 deaths annually. For decades, chloroquine was used to treat malaria until Plasmodium falciparum developed resistance. Now, a drug combination — artemether and lumefantrine — is the primary treatment for malaria although resistance is also developing to the drug combination in some countries.
Researchers recruited 66 adult men in Mali with uncomplicated malaria, which is defined as malaria that isn’t life threatening. Half were treated with AQ-13 and the other half received artemether and lumefantrine. Both drug groups had similar cure rates. However, five participants in AQ-13 group left the study or were lost to follow-up and two participants in the artemether/lumefantrine group had late treatment failures with recurrence of their original infections.
Researchers hope to expand testing of the drug to more participants, including women and children, before it can be widely recommended as a new treatment. Krogstad said that the same biotechnology that helped the team develop the new drug has also identified similar drugs that also hold promise against drug-resistant parasites.
The Latest on: Malaria
- Daniel Dae Kim believes malaria drug was the 'secret weapon' in his coronavirus recoveryon March 22, 2020 at 6:49 pm
Actor Daniel Dae Kim says a medication commonly used to treat malaria was "crucial" in his recovery from coronavirus. Kim, 51, described the malaria drug hydroxychloroquine as the "secret weapon" in ...
- From malaria to coronavirus: What Pensacola history has taught us about disease outbreakson March 22, 2020 at 5:00 am
Looking back at epidemics throughout Pensacola history, experts have often shared the same kinds of advice: limit contact ...
- Trump Still Promoting Untested Malaria Drug As Coronavirus 'Game Changer' Despite Dr. Fauci's Objection, FDA Denialson March 21, 2020 at 2:15 pm
President Trump on Saturday continued to hype an anti-malaria drug as a cure for coronavirus, drawing heavy criticism from health experts on social media. “HYDROXYCHLOROQUINE & AZITHROMYCIN, taken ...
- Toxicologist says anti-malaria drugs show 'promise' in treating coronaviruson March 21, 2020 at 8:37 am
Malaria drugs are showing "promising" initial results as a potential coronavirus treatment, a toxicologist and economic researcher said Saturday. Appearing on "Fox & Friends Weekend," Dr. Chris ...
- Federal government looks to malaria drug as possible coronavirus treatmenton March 21, 2020 at 5:20 am
President Trump announced that a drug commonly used to treat malaria could possibly be used to treat coronavirus symptoms, after it goes through clinical trials. However, officials maintained that ...
- Malaria drugs touted by Trump can work against coronavirus, top doc tells Laura Ingrahamon March 20, 2020 at 9:43 pm
Data show that anti-malaria drugs touted by President Trump can help in treating coronavirus patients, a top oncologist said Friday on Fox News' "The Ingraham Angle." Dr. William Grace of Lenox Hill ...
- ‘Anecdotal Evidence,’ Dr. Fauci Says of Malaria Drug Claimon March 20, 2020 at 2:43 pm
Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases, corrected President Trump’s earlier suggestion that a malaria drug could cure coronavirus. “Dr. Fauci, ...
- Fauci throws cold water on Trump's declaration that malaria drug chloroquine is a 'game changer'on March 20, 2020 at 2:39 pm
Infectious disease expert Anthony Fauci throws cold water on Trump's insistence that one drug is a “game changer” in the fight against novel coronavirus.
- Doctors Turn to Malaria Drugs as Potential Coronavirus Treatmenton March 20, 2020 at 11:44 am
Doctors and hospitals are turning to decades-old antimalarial drugs to treat patients infected with the disease caused by the new coronavirus, as they work to repurpose existing therapies in a race to ...
- Fauci says malaria drug's effectiveness on COVID-19 is "anecdotal"on March 20, 2020 at 10:32 am
President Trump also said he's put the Defense Production Act "into gear" to ramp up production of much-needed medical equipment.
via Google News and Bing News